These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 37941063)
61. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related]
62. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274 [TBL] [Abstract][Full Text] [Related]
63. The role of LncRNA MCM3AP-AS1 in human cancer. Azizidoost S; Ghaedrahmati F; Sheykhi-Sabzehpoush M; Uddin S; Ghafourian M; Mousavi Salehi A; Keivan M; Cheraghzadeh M; Nazeri Z; Farzaneh M; Khoshnam SE Clin Transl Oncol; 2023 Jan; 25(1):33-47. PubMed ID: 36002764 [TBL] [Abstract][Full Text] [Related]
64. Long non-coding RNA ADAMTS9-AS1 suppresses colorectal cancer by inhibiting the Wnt/β-catenin signalling pathway and is a potential diagnostic biomarker. Li N; Li J; Mi Q; Xie Y; Li P; Wang L; Binang H; Wang Q; Wang Y; Chen Y; Wang Y; Mao H; Du L; Wang C J Cell Mol Med; 2020 Oct; 24(19):11318-11329. PubMed ID: 32889785 [TBL] [Abstract][Full Text] [Related]
65. DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through Vera O; Jimenez J; Pernia O; Rodriguez-Antolin C; Rodriguez C; Sanchez Cabo F; Soto J; Rosas R; Lopez-Magallon S; Esteban Rodriguez I; Dopazo A; Rojo F; Belda C; Alvarez R; Valentin J; Benitez J; Perona R; De Castro J; Ibanez de Caceres I Theranostics; 2017; 7(17):4118-4134. PubMed ID: 29158814 [TBL] [Abstract][Full Text] [Related]
66. LncRNA SBF2-AS1: A Budding Star in Various Cancers. Tan F; Chen J; Wang B; Du Z; Mou J; Wu Y; Liu Y; Zhao F; Yuan C Curr Pharm Des; 2022; 28(18):1513-1522. PubMed ID: 35440300 [TBL] [Abstract][Full Text] [Related]
67. LncRNA TRHDE-AS1 and MiR-1275 as Promising Prognostic Biomarkers and Effects on Tumor Cell Progression in Gastric Cancer. Liu F; Cui J; Xue D Tohoku J Exp Med; 2023 Sep; 261(1):13-23. PubMed ID: 36792178 [TBL] [Abstract][Full Text] [Related]
68. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer. Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703 [TBL] [Abstract][Full Text] [Related]
69. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
70. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer. Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831 [TBL] [Abstract][Full Text] [Related]
71. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis. Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023 [TBL] [Abstract][Full Text] [Related]
72. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer. Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052 [TBL] [Abstract][Full Text] [Related]
73. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression. Shi L; Hong X; Ba L; He X; Xiong Y; Ding Q; Yang S; Peng G Cell Death Dis; 2019 Feb; 10(3):150. PubMed ID: 30770796 [TBL] [Abstract][Full Text] [Related]
74. LncRNA TTN-AS1 sponges miR-376a-3p to promote colorectal cancer progression via upregulating KLF15. Wang Y; Jiang F; Xiong Y; Cheng X; Qiu Z; Song R Life Sci; 2020 Mar; 244():116936. PubMed ID: 31610194 [TBL] [Abstract][Full Text] [Related]
75. Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Zhang J; Feng S; Su W; Bai S; Xiao L; Wang L; Thomas DG; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Beer DG; Guo YM; Chen G Sci Rep; 2017 Feb; 7():42819. PubMed ID: 28198463 [TBL] [Abstract][Full Text] [Related]
76. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196/OTX1 axis in breast cancer. Yang J; Wu W; Wu M; Ding J In Vitro Cell Dev Biol Anim; 2019 Aug; 55(7):522-532. PubMed ID: 31264061 [TBL] [Abstract][Full Text] [Related]
77. LncRNA NNT-AS1 promotes the proliferation, and invasion of lung cancer cells via regulating miR-129-5p expression. Shen Q; Jiang Y Biomed Pharmacother; 2018 Sep; 105():176-181. PubMed ID: 29857296 [TBL] [Abstract][Full Text] [Related]
78. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis. Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046 [TBL] [Abstract][Full Text] [Related]
79. Long noncoding RNA MNX1-AS1 contributes to lung cancer progression through the miR-527/BRF2 pathway. Liu H; Han L; Liu Z; Gao N J Cell Physiol; 2019 Aug; 234(8):13843-13850. PubMed ID: 30618167 [TBL] [Abstract][Full Text] [Related]
80. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer. Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]